Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER_GOV × Blood Specimen Collection × Endocrine × Clear all

Status

Sponsor Class

OTHER 8 OTHER_GOV 1

Study Type

Observational 1

Sponsor

Cancer Type

CNS 3 Thoracic 2 Head & Neck 2 Gastrointestinal 2 Other hematologic neoplasm 1 Gynecologic 1 Genitourinary 1 Endocrine 1 Breast 1

Conditions

Thyroid Carcinoma, Anaplastic 1

Interventions

Observation 2 pembrolizumab 1 olaparib 1 lenvatinib 1 copper dotatate CU-64 1 Tomography, Emission-Computed, Single-Photon 1 Thyroidectomy 1 Reverse Transcriptase Polymerase Chain Reaction 1 PM 01183 1 Lymph Node Excision 1 Lutetium-177 1 Irinotecan 1 Iodine-124 1 Iodine-123 1 Injections 1 Histocompatibility Testing 1 Etoposide 1 Cisplatin 1 Catecholamines 1 Capecitabine 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01774279 2021-01-05

iNATT

Velindre NHS Trust

EndocrineHead & Neck

Thyroid Carcinoma, Anaplastic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡